Pharmacogenomics in cancer

Pharmacogenomics studies how medicine interacts with inherited genes. Here is the latest research on pharmacogenomics in cancer.

June 12, 2020
Open Access

A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities

Nature Communications
Ravi S NarayanBart A Westerman
April 30, 2020
Preprint
Open Access

Genome-Wide Meta-Analysis Identifies a S1PR1 Genomic Region Associated with Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

MedRxiv : the Preprint Server for Health Sciences
K. C. ChuaDeanna L Kroetz
June 25, 2020
Open Access

The genetic and pharmacogenomic landscape of snoRNAs in human cancer

Molecular Cancer
Yaoming LiuLeng Han
June 26, 2020
Open Access

Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population

Scientific Reports
Darlen Cardoso de CarvalhoNey Pereira Carneiro Dos Santos
May 20, 2020

Association between metformin medication, genetic variation and prostate cancer risk

Prostate Cancer and Prostatic Diseases
Min Joon LeeRobert J Hamilton
May 22, 2020

CELLector: Genomics-Guided Selection of Cancer In Vitro Models

Cell Systems
Hanna NajgebauerFrancesco Iorio
April 18, 2020
Open Access

Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jarle BruunRagnhild A Lothe
February 20, 2020
Open Access

Comprehensive pharmacogenomic characterization of gastric cancer

Genome Medicine
Jason K SaJeeyun Lee
July 8, 2020

Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients

Breast Cancer Research and Treatment
Adrienne E BorrieRichard B Kim
April 6, 2020

Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Wen-Li LuoJian Luo
February 28, 2020

Peripheral T cell expansion predicts tumour infiltration and clinical response

Nature
Thomas D WuJane L Grogan
February 13, 2020
Review
Open Access

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

British Journal of Cancer
Eric P AllainChantal Guillemette
May 1, 2020
Review
Open Access

Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies

Frontiers in Oncology
Chiara Caruso, Cecilia Garofalo
June 25, 2020
Review
Open Access

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

Journal of Clinical Medicine
Ramon Andrade De MelloGeorgios Antoniou
July 1, 2020

Pharmacogenetics in the treatment of gastrointestinal stromal tumors- an updated review

Expert Opinion on Drug Metabolism & Toxicology
Gloria RavegniniSabrina Angelini
June 21, 2020

Genome-Wide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

Clinical Pharmacology and Therapeutics
Katherina C ChuaDeanna L Kroetz

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Biodiversity Data

Biodiversity refers to the variety and variability of life on Earth. Biodiversity is typically a measure of variation at the genetic, species, and ecosystem level.Discover the latest research on biodiversity data here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

© 2020 Meta ULC. All rights reserved
/feed-previews/pharmacogenomics-in-cancer/3d4ce0ec-d1af-475d-8344-562343316c3b